Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers.
about
Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsThe effect of environmental oxidative stress on airway inflammationNeutrophilic inflammation is associated with altered airway hydration in stable asthmaticsDeregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients.Atopic asthmatic subjects but not atopic subjects without asthma have enhanced inflammatory response to ozone.Environmental effects on immune responses in patients with atopy and asthma.Ambient PM2.5 exposure up-regulates the expression of costimulatory receptors on circulating monocytes in diabetic individualsGSTM1 modulation of IL-8 expression in human bronchial epithelial cells exposed to ozoneSRC-mediated EGF receptor activation regulates ozone-induced interleukin 8 expression in human bronchial epithelial cells.Low-level ozone exposure induces airways inflammation and modifies cell surface phenotypes in healthy humans.Comparative airway inflammatory response of normal volunteers to ozone and lipopolysaccharide challengeSB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humansEfficacy and safety of inhaled calcium lactate PUR118 in the ozone challenge model--a clinical trial.The glutathione-S-transferase mu 1 (GSTM1) null genotype and increased neutrophil response to low-level ozone (0.06 ppm).Individuals with increased inflammatory response to ozone demonstrate muted signaling of immune cell trafficking pathways.Resolution of cell-mediated airways diseases.Do corticosteroids have a role in preventing or reducing acute toxic lung injury caused by inhalation of chemical agents?The role of oxidative stress and innate immunity in O(3) and endotoxin-induced human allergic airway disease.Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature.Unifying thoracic biomarkers: surfactant protein-D and beyond.Challenge models to assess new therapies in chronic obstructive pulmonary disease.Newly divided eosinophils limit ozone-induced airway hyperreactivity in nonsensitized guinea pigs.Environmental tobacco smoke exposure, urine CC-16 levels, and asthma outcomes among Chinese children.Ozone exposure enhances mast-cell inflammation in asthmatic airways despite inhaled corticosteroid therapy
P2860
Q26766294-8D7B0B79-AEC5-4139-98E3-22F358342C0DQ28730761-E7FDB27A-049F-4423-88EF-2CEF4D901D35Q33636016-3CA59EFD-C19D-4BF0-B7E8-1B9BB031D5B0Q33866409-3F8913D0-5B56-45CF-9314-59EF47A3427EQ34171493-4658858E-4629-4DAC-A393-DCBE68023074Q34626121-2C102BBE-BA34-4217-89A6-5FADED5B9B66Q35044733-EFB7E7F5-7506-43EC-B1F7-6C55AEF8CBA9Q35099151-95F0C847-2A27-4BCB-B3A1-A1FCDF481F39Q35144616-8A345659-9E6B-4D6E-9F66-01F9EDDED7AEQ35183078-3389F2D4-C45D-4459-9C82-4694203110D6Q35183080-2314EAF9-0509-48A6-A82D-0CDBF7F7B530Q35183636-BF5D9919-EC48-4BC3-A622-8858974FC708Q35743384-00F7C9D5-775F-4B2A-A2D8-F021689DE55CQ36431407-404E0299-0177-496A-B77F-8E95852F48DDQ36715787-27714472-1EA5-4E95-BE60-328076D8F784Q37764375-EB8A5759-9EB4-473F-A89F-0CC93A8F23EBQ37849299-A027026B-2BA4-436E-9040-A0289F243742Q37891127-1AF322F0-6502-462A-A666-9E1393950FA1Q37937720-21CD4F85-EEBC-4780-B196-954475A2C035Q37997815-8000D626-648F-4E67-BE38-C0A09CF21630Q38051306-05E396B3-C833-4D25-AE0E-40A21F2254A1Q47960048-C0B54964-FB16-4D44-A7EE-B56654BB19E5Q51675843-73DBDDC7-6493-4CF1-A5AD-EAC1DF3D5F5FQ57269364-C540E26E-D24F-44AC-89E0-67DF0A28ECC8
P2860
Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Fluticasone propionate protect ...... markers in healthy volunteers.
@ast
Fluticasone propionate protect ...... markers in healthy volunteers.
@en
type
label
Fluticasone propionate protect ...... markers in healthy volunteers.
@ast
Fluticasone propionate protect ...... markers in healthy volunteers.
@en
prefLabel
Fluticasone propionate protect ...... markers in healthy volunteers.
@ast
Fluticasone propionate protect ...... markers in healthy volunteers.
@en
P2093
P2860
P356
P1476
Fluticasone propionate protect ...... markers in healthy volunteers.
@en
P2093
Brad Harris
David B Peden
Henry Gong
John C Lay
Milan J Hazucha
Neil E Alexis
William Linn
P2860
P304
P356
10.1289/EHP.10981
P577
2008-06-01T00:00:00Z